PET scans in radiotherapy planning of lung cancer☆

Received 4 June 2010; received in revised form 7 July 2010; accepted 7 July 2010. published online 26 July 2010.

Abstract

Especially for non-small cell lung cancer, FDG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.

Keywords: Radiotherapy, PET, Lung cancer, Delineation, Target volumes

a Department of Radiation Oncology (MAASTRO Clinic), Maastricht University Medical Center, The Netherlands

b Department of Nuclear Medicine, Saarland University Medical Center, Homburg, Germany

Corresponding author. Address: Maastricht University Medical Center, Department of Radiation Oncology (MAASTRO Clinic), GROW Research Institute, Maastricht, The Netherlands.

☆ Guidelines for the use of PET in radiotherapy planning A. Chiti (EANM) and V. Grégoire (ESTRO).

PII: S0167-8140(10)00385-3

doi:10.1016/j.radonc.2010.07.002

14 of 18